COA Checker

Peptide Testing

Peptide testing is the set of lab tests that describe one batch of a peptide: what it is, how clean it is, and what else is in it.

Prefer

Last updated October 18, 2026

Learn

The short version

No single test covers all of that. Purity by HPLC is only one line. EU guidance for peptide medicines lists more than ten kinds of test a full specification may hold. A research COA may show only a few of them.

This page goes through the tests, what each one answers, and how it shows up on a COA. The COA peptide checker walks through the tests listed on your own COA.

Sources: European Medicines Agency guideline on synthetic peptides, 2025, for the count of test types in a full specification.

The tests, one by one

The European Medicines Agency (EMA) guideline on synthetic peptides, in effect from June 2026, lists what a peptide's specification may include. Here are tests from that list, in plain words.

TestThe question it answersMethods named in the EMA guideline
AppearanceWhat does it look like?Looking at the powder, and at the solution if relevant
IdentityWhich molecule is it?Two or more of: mass, retention time, LC-MS, peptide mapping, amino acid analysis, NMR
PurityHow big is the main peak next to the other counted peaks?HPLC with UV
Assay or contentHow much of the powder is the peptide?HPLC against a standard, amino acid analysis, nitrogen analysis, qNMR
CounterionWhich salt is it, and how much?Liquid chromatography or ion chromatography
Water contentHow much water is in the powder?Not named in the list
Residual solventsAre solvents from making it left over?Not named in the list
Bacterial endotoxinsAre bacterial cell wall parts present?Not named there; FDA lists gel clot, turbidimetric and chromogenic tests under USP chapter 85
Microbial purityAre living microbes present?Not named in the list

Sources: European Medicines Agency guideline on the development and manufacture of synthetic peptides, 2025, section 4.4; US Pharmacopeia chapter 621, Chromatography, 2022 text, for the purity question; FDA presentation The Bacterial Endotoxins Specification: Points to Consider, for the three endotoxin methods.

Identity: is it the right molecule?

Identity is about which molecule is there. Mass spectrometry (MS) is one tool. USP describes it as measuring the mass to charge ratio of ions made from the sample. An intact mass gives a number to compare with the molecule's mass, but on its own it does not establish identity. EU guidance notes that variants of MS, such as tandem MS (LC-MS/MS), can confirm the amino acid sequence.

EU guidance suggests at least two different methods for identity. One reason: some swaps do not change the mass at all. Leucine and isoleucine weigh exactly the same. A second method, such as amino acid analysis or retention time, can catch what one method misses.

Sources: US Pharmacopeia chapter 736, public introduction, for the mass to charge ratio; European Medicines Agency guideline on synthetic peptides, 2025, sections 4.3 and 4.4, for sequence by MS and the advice to use two methods.

Purity and content are not the same

Purity asks what share of the included HPLC peak area is the main peak. Content asks how much of the powder's weight is the peptide. A powder with high purity can still be part water and part salt. The peptide purity page shows a worked example.

The salt part can be large. In a 2025 study, TFA was up to 35 percent of the weight of a peptide salt. EU guidance asks that assay limits be given on a salt free, water free basis.

Sources: US Pharmacopeia chapter 621, Chromatography, 2022 text, for purity as the main peak's share; the 2025 paper on TFA as a counterion in synthetic peptides, in the journal Pharmaceuticals; European Medicines Agency guideline on synthetic peptides, 2025, for the basis of assay limits.

Endotoxin and sterility

These two are different tests. Sterility testing checks for live microbes. Endotoxin testing checks for parts of the cell walls of Gram-negative bacteria. Most sterilization methods leave endotoxins intact, FDA notes. So a sterile product can still hold endotoxin. The endotoxin test page explains the methods and units.

Sources: FDA presentation The Bacterial Endotoxins Specification: Points to Consider, on sterilization and endotoxins.

What third party testing means

Third party testing means a lab that is not the seller tests a sample. The lab can only report on the sample it received. It cannot vouch for every vial sold under that batch number. The batch number is the link, so compare it with your vial. Then ask the lab to confirm the report. See COA verification.

What a COA may leave out

Some COAs show only purity and mass. Compared with the EMA list, such a COA lacks:

  • peptide content or assay,
  • water and counterion content,
  • endotoxin and sterility,
  • limits next to each result,
  • a signed and dated sign off.

A missing test is not a result either way. It means that question was not answered on that page.

Sources: European Medicines Agency guideline on synthetic peptides, 2025, section 4.4, for the tests; FDA Q7 guidance, 2016, for limits and the signed sign off.

Questions

What is peptide testing?

Peptide testing is the set of lab tests that describe one batch of a peptide. Tests can include mass by mass spectrometry, purity by HPLC, peptide content, water, counterion, endotoxin and sterility. A COA reports the tests that were run, with limits and results.

What is third party peptide testing?

Third party peptide testing means a lab that is not the seller tests a sample. The lab reports on the sample it received. To tie that report to your vial, compare the batch number, then ask the lab to confirm the report through its own site or by email.

What do peptide testing labs test for?

Lab menus differ, so the COA is the record of what was run. Tests can include purity by HPLC and mass by mass spectrometry, and a COA may add content, water, counterion, endotoxin and sterility. Look for a method, a limit and a result on each test line.

What does peptide quality testing cover?

For peptide medicines, EU guidance lists appearance, identity, purity, assay, counterion, water, residual solvents, metals, endotoxin and microbial tests. A research COA may show fewer. Check which tests your COA lists and which it leaves out.

Sources: European Medicines Agency guideline on synthetic peptides, 2025, section 4.4, for the tests named in these answers; FDA Q7 guidance, 2016, paragraph 11.42, for limits and results on a COA.

Sources

6 sources with read dates
  1. Guideline on the Development and Manufacture of Synthetic Peptides, European Medicines Agency, EMA/CHMP/CVMP/QWP/367182/2025, sections 4.3 and 4.4, read 2026-10-06
  2. General Chapter 736, Mass Spectrometry, United States Pharmacopeia, public introduction read 2026-10-06
  3. General Chapter 621, Chromatography, harmonized text official 1 December 2022, United States Pharmacopeia; the copy of USP's own file kept by the Internet Archive on 7 December 2023, normalization procedure, read 2026-10-08
  4. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides, Pharmaceuticals (Basel) 2025, PMID 40872554; full text read on PubMed Central (PMC12389442), read 2026-10-06
  5. The Bacterial Endotoxins Specification: Points to Consider, FDA Center for Drug Evaluation and Research, read 2026-10-06
  6. Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, FDA, September 2016, section 11.4, read 2026-10-06